Digital Health for Medication Adherence Among African Americans With Hypertension

Completed · Not applicable

Conditions studied: Hypertension

In brief

The proposed Phase 1 project aims to develop and test Memento.HTN, an individually-tailored, culturally sensitive digital health intervention comprised of a provider platform and linked patient SMS (short message service) text system to promote medication adherence among African Americans with hypertension (HTN), a group that suffers from disproportionate HTN morbidity and mortality. Memento.HTN overcomes access barriers on the part of patients and adherence support implementation barriers on the part of healthcare teams and systems. Memento.HTN is innovative in three key ways: 1) it is the first-ever linked digital provider platform and patient SMS text system for HTN medication adherence; 2) it is culturally-tailored for African Americans with HTN; and 3) it has unique monitoring functionality allowing providers to monitor individual patient adherence, support 'new start' patients, and track group adherence rates by drug class, pill format, and patient demographics.

Key facts

Study ID

NCT05009004

Run by

Environment and Health Group, Inc.

People needed

22

Starts

2022-10-14

Expected to finish

2023-10-30

Last updated by the study team

2024-12-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Self-identify as African American, age 18 \& older, diagnosed with hypertension and on meds for it, own a cellphone (basic or smart) -

You may not qualify if…

• Participation in other clinical research; undergoing cancer treatment; pregnancy; end stage renal disease

Where it is running

• Environment and Health Group — Cambridge, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.